Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Toxics ; 12(7)2024 Jun 21.
Article in English | MEDLINE | ID: mdl-39058097

ABSTRACT

Imidacloprid (IMI) is a commonly used new-generation pesticide that has numerous harmful effects on non-targeted organisms, including animals. This study analysed both the adverse effects on the pancreas following oral consumption of imidacloprid neonicotinoids (45 mg/kg daily for 30 days) and the potential protective effects of lycopene (LYC) administration (10 mg/kg/day for 30 days) with IMI exposure in male Sprague-Dawley rats. The apoptotic, pyroptotic, inflammatory, oxidative stress, and endoplasmic reticulum stress biomarkers were evaluated, along with the histopathological alterations. Upon IMI administration, noticeable changes were observed in pancreatic histopathology. Additionally, elevated oxidative/endoplasmic reticulum-associated stress biomarkers, inflammatory, pyroptotic, and apoptotic biomarkers were also observed following IMI administration. LYC effectively reversed these alterations by reducing oxidative stress markers (e.g., MDA) and enhancing antioxidant enzymes (SOD, CAT). It downregulated ER stress markers (IRE1α, XBP1, CHOP), decreased pro-inflammatory cytokines (TNF-α, IL-1ß), and suppressed pyroptotic (NLRP3, caspase-1) along with apoptotic markers (Bax, cleaved caspase-3). It also improved the histopathological and ultrastructure alterations brought on by IMI toxicity.

2.
Life Sci ; 290: 120265, 2022 Feb 01.
Article in English | MEDLINE | ID: mdl-34968465

ABSTRACT

Fenitrothion (FNT), a commonly used organophosphate, can cause oxidative damage and apoptosis on various organs. However, the underlying mechanisms for FNT-induced cardiotoxicity did not formally report. Here, we have evaluated the possible ameliorative roles of resveratrol (RSV) against FNT-induced cardiac apoptosis in male rats through the sirtuin1 (SIRT1)/c-Jun N-terminal kinase (c-JNK)/p53 pathway concerning pro-oxidant and inflammatory cytokines. Forty-eight male rats were equally grouped into control, RSV (20 mg/kg), 5-FNT (5 mg/kg), 10-FNT (10 mg/kg), 20-FNT (20 mg/kg), 5-FNT-RSV, 10-FNT-RSV, and 20-FNT-RSV where all doses administrated by gavage for four weeks. The present findings demonstrated that RSV markedly diminished the level of hyperlipidemia and elevation in lactate dehydrogenase (LDH), total creatine kinase (CK-T), and troponin T (TnT) levels following FNT intoxication. Furthermore, RSV significantly reduced FNT-induced cardiac oxidative injury by reducing malondialdehyde (MDA) level and improving the levels of glutathione (GSH), glutathione reductase (GR), superoxide dismutase (SOD), catalase (CAT), and acetylcholinesterase (AchE). Also, the levels of interleukin-1ß (IL1ß,), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) were significantly attenuated in the co-treated groups. Moreover, RSV alleviated the histopathological changes promoted by FNT and repaired the transcript levels of SIRT1, c-JNK, and caspase-9/3 along with p53 immunoreactivity. In silico study revealed that the free binding energies of RSV complexes with protein and DNA sequences of SIRT1 were lower than docked complexes of FNT. Therefore, RSV reserved myocardial injury-induced apoptosis following exposure to FNT by modulating the SIRT1/c-JNK/p53 pathway through cellular redox status and inflammatory response improvements.


Subject(s)
Fenitrothion/toxicity , Myocytes, Cardiac/metabolism , Resveratrol/pharmacology , Acetylcholinesterase/metabolism , Animals , Antioxidants/metabolism , Apoptosis/drug effects , Cardiotoxicity/drug therapy , Fenitrothion/adverse effects , Fenitrothion/pharmacology , Glutathione/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Male , Myocytes, Cardiac/drug effects , Oxidation-Reduction , Oxidative Stress , Rats , Reactive Oxygen Species/metabolism , Resveratrol/metabolism , Signal Transduction , Sirtuin 1/metabolism , Superoxide Dismutase/metabolism , Tumor Suppressor Protein p53/metabolism
3.
J Biochem Mol Toxicol ; 34(4): e22451, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31975531

ABSTRACT

Dapagliflozin (DAPA) is used for treating type 2 diabetes, whereas lansoprazole (LPZ) is used as a traditional antiulcer drug. The present study investigated the possible antidiabetic effects of LPZ on fortified diet-fed streptozotocin (FDF/STZ)-induced insulin-resistant diabetic rats. On the basis of the current results, it can be concluded that LPZ could be used as an add-on drug along with the conventional treatment for T2D as it showed beneficial effects in the current experimental model of insulin resistance.


Subject(s)
Benzhydryl Compounds/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Glucosides/therapeutic use , Hypoglycemic Agents/therapeutic use , Insulin Resistance , Lansoprazole/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors/therapeutic use , Animals , Blood Glucose/analysis , Blood Glucose/drug effects , Body Weight/drug effects , Cholesterol/blood , Cholesterol/metabolism , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/etiology , Diabetes Mellitus, Experimental/metabolism , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination , Food, Fortified/adverse effects , Glucose Transporter Type 2/genetics , Glucose Transporter Type 2/metabolism , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Male , Oxidative Stress/drug effects , PPAR gamma/blood , Pancreas/metabolism , Pancreas/pathology , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL